Jitendra Wadhane - Mar 31, 2025 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
SVP, Chief Accounting Officer
Signature
/s/ Jitendra Wadhane
Stock symbol
PYXS
Transactions as of
Mar 31, 2025
Transactions value $
$258,506
Form type
4
Date filed
4/2/2025, 09:04 AM
Previous filing
Dec 23, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PYXS Stock Option (Right to Buy) Award $259K +264K $0.98 264K Mar 31, 2025 Common Stock 264K $0.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 31,2025 and the remainder vesting in 36 equal monthly instalments thereafter subject to the reporting person's continued employment through the applicable vesting date.